Research Priorities for Article 14-Demand Reduction Measures Concerning Tobacco Dependence and Cessation

Research Priorities for Article 14-Demand Reduction Measures Concerning Tobacco Dependence and Cessation

Author McRobbie, Hayden Google Scholar
Raw, Martin Autor UNIFESP Google Scholar
Chan, Sophia Google Scholar
Institution Univ Nottingham
Queen Mary Univ London
Sch Publ Hlth & Psychosocial Studies
Auckland Univ Technol
Universidade Federal de São Paulo (UNIFESP)
Univ Hong Kong
Abstract Introduction: Tobacco dependence treatment (TDT) interventions are often seen as expensive with little impact on the prevalence of tobacco use. However, activities that promote the cessation of tobacco use and support abstinence have an important role in any comprehensive tobacco control program and as such are recognized within Article 14 (A14) of the Framework Convention on Tobacco Control.Objectives: To review current evidence for TDT and recommend research priorities that will contribute to more people being helped to stop tobacco use.Methods: We used the recommendations within the A14 guidelines to guide a review of current evidence and best practice for promotion of tobacco cessation and TDT, identify gaps, and propose research priorities.Results: We identified nine areas for future research (a) understanding current tobacco use and the effect of policy on behavior, (b) promoting cessation of tobacco use, (c) implementation of TDT guidelines, (d) increasing training capacity, (e) enhancing population-based TDT interventions, (f) treatment for different types of tobacco use, (g) supply of low-cost pharmaceutical devices/products, (h) investigation use of nonpharmaceutical devices/products, and (i) refinement of current TDTs. Specific research topics are suggested within each of these areas and recognize the differences needed between high- and low-/middle-income countries.Conclusions: Research should be prioritized toward examining interventions that (a) promote cessation of tobacco use, (b) assist health care workers provide better help to smokers (e.g., through implementation of guidelines and training), (c) enhance population-based TDT interventions, and (d) assist people to cease the use of other tobacco products.
Language English
Sponsor National Cancer Institute
manufacturers of stop smoking medications
Johnson and Johnson
Grant number National Cancer Institute: HHSN261201100185P
Date 2013-04-01
Published in Nicotine & Tobacco Research. Oxford: Oxford Univ Press, v. 15, n. 4, p. 805-816, 2013.
ISSN 1462-2203 (Sherpa/Romeo, impact factor)
Publisher Oxford Univ Press
Extent 805-816
Access rights Closed access
Type Review
Web of Science ID WOS:000316776700006

Show full item record


File Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)




My Account